Mural Oncology (MURA) Competitors $3.95 -0.19 (-4.59%) As of 01/22/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MURA vs. MBIO, ACIU, HRTX, AMLX, NGNE, ATAI, DMAC, URGN, ELDN, and LFCRShould you be buying Mural Oncology stock or one of its competitors? The main competitors of Mural Oncology include Mustang Bio (MBIO), AC Immune (ACIU), Heron Therapeutics (HRTX), Amylyx Pharmaceuticals (AMLX), Neurogene (NGNE), Atai Life Sciences (ATAI), DiaMedica Therapeutics (DMAC), UroGen Pharma (URGN), Eledon Pharmaceuticals (ELDN), and Lifecore Biomedical (LFCR). These companies are all part of the "pharmaceutical products" industry. Mural Oncology vs. Mustang Bio AC Immune Heron Therapeutics Amylyx Pharmaceuticals Neurogene Atai Life Sciences DiaMedica Therapeutics UroGen Pharma Eledon Pharmaceuticals Lifecore Biomedical Mural Oncology (NASDAQ:MURA) and Mustang Bio (NASDAQ:MBIO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, community ranking, valuation, dividends and media sentiment. Does the MarketBeat Community favor MURA or MBIO? Mustang Bio received 164 more outperform votes than Mural Oncology when rated by MarketBeat users. However, 100.00% of users gave Mural Oncology an outperform vote while only 64.26% of users gave Mustang Bio an outperform vote. CompanyUnderperformOutperformMural OncologyOutperform Votes5100.00% Underperform VotesNo VotesMustang BioOutperform Votes16964.26% Underperform Votes9435.74% Do analysts rate MURA or MBIO? Mural Oncology presently has a consensus price target of $16.00, indicating a potential upside of 305.06%. Mustang Bio has a consensus price target of $100.00, indicating a potential upside of 2,298.08%. Given Mustang Bio's higher possible upside, analysts clearly believe Mustang Bio is more favorable than Mural Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mural Oncology 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Mustang Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, MURA or MBIO? Mural Oncology has a beta of 3.83, indicating that its share price is 283% more volatile than the S&P 500. Comparatively, Mustang Bio has a beta of 1.77, indicating that its share price is 77% more volatile than the S&P 500. Is MURA or MBIO more profitable? Mustang Bio's return on equity of 0.00% beat Mural Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Mural OncologyN/A -70.10% -61.30% Mustang Bio N/A N/A -172.89% Do institutionals and insiders hold more shares of MURA or MBIO? 80.2% of Mural Oncology shares are owned by institutional investors. Comparatively, 10.0% of Mustang Bio shares are owned by institutional investors. 0.1% of Mural Oncology shares are owned by insiders. Comparatively, 0.6% of Mustang Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media refer more to MURA or MBIO? In the previous week, Mustang Bio had 4 more articles in the media than Mural Oncology. MarketBeat recorded 4 mentions for Mustang Bio and 0 mentions for Mural Oncology. Mural Oncology's average media sentiment score of 0.00 beat Mustang Bio's score of -0.15 indicating that Mural Oncology is being referred to more favorably in the media. Company Overall Sentiment Mural Oncology Neutral Mustang Bio Neutral Which has stronger valuation & earnings, MURA or MBIO? Mural Oncology is trading at a lower price-to-earnings ratio than Mustang Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMural OncologyN/AN/A-$207.45M-$9.14-0.43Mustang BioN/AN/A-$51.60M-$78.00-0.05 SummaryMural Oncology beats Mustang Bio on 9 of the 16 factors compared between the two stocks. Get Mural Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for MURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MURA vs. The Competition Export to ExcelMetricMural OncologyPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$67.23M$6.55B$5.39B$9.24BDividend YieldN/A2.96%5.37%3.99%P/E Ratio-0.439.8989.1117.52Price / SalesN/A334.651,221.8479.25Price / CashN/A64.1243.6036.96Price / Book0.255.105.014.72Net Income-$207.45M$154.66M$117.81M$224.61M7 Day Performance7.05%1.64%2.03%1.55%1 Month Performance24.21%1.88%4.03%5.12%1 Year Performance-10.02%4.70%26.78%21.25% Mural Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MURAMural Oncology3.2515 of 5 stars$3.95-4.6%$16.00+305.1%-10.0%$70.46MN/A0.00119MBIOMustang Bio2.3266 of 5 stars$5.55-5.6%$100.00+1,701.8%-93.9%$265.18MN/A-3.56100Stock SplitACIUAC Immune2.1749 of 5 stars$2.68+1.5%$12.00+347.8%-33.1%$265.16M$40.97M-5.83140Positive NewsHRTXHeron Therapeutics3.8903 of 5 stars$1.63+3.8%$5.67+247.6%-30.3%$247.92M$127.04M-9.06300Analyst UpgradeAMLXAmylyx Pharmaceuticals3.0724 of 5 stars$3.60+2.9%$7.33+103.7%-76.3%$246.78M$380.79M-0.94200NGNENeurogene2.6778 of 5 stars$16.60-5.8%$60.83+266.5%-47.0%$246.51MN/A0.0090Gap DownATAIAtai Life Sciences1.5861 of 5 stars$1.46+5.0%$9.00+516.4%-16.5%$244.99M$310,000.00-1.8080DMACDiaMedica Therapeutics0.6931 of 5 stars$5.71+0.7%$7.00+22.6%+116.1%$244.16MN/A-10.2020News CoverageGap DownHigh Trading VolumeURGNUroGen Pharma3.7232 of 5 stars$10.27-2.4%$43.70+325.5%-33.1%$240.87M$89.36M-3.26200ELDNEledon Pharmaceuticals2.7034 of 5 stars$4.02-0.2%$16.00+298.0%+142.0%$240.16MN/A-2.0010Analyst RevisionNews CoverageLFCRLifecore Biomedical1.7077 of 5 stars$6.48+0.6%$8.00+23.5%-5.7%$239.95M$128.26M-11.57690 Related Companies and Tools Related Companies Mustang Bio Competitors AC Immune Competitors Heron Therapeutics Competitors Amylyx Pharmaceuticals Competitors Neurogene Competitors Atai Life Sciences Competitors DiaMedica Therapeutics Competitors UroGen Pharma Competitors Eledon Pharmaceuticals Competitors Lifecore Biomedical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MURA) was last updated on 1/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
